-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q8szmtpPCnYHDeflZ0Y1+sdL2/f8PhX2nwzOf6LpsXJlNylW5kQe4vJjB1lFXe9U GEEGRZFtFH+Kwsgth8nlYw== 0001419041-09-000007.txt : 20090618 0001419041-09-000007.hdr.sgml : 20090618 20090618134502 ACCESSION NUMBER: 0001419041-09-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090618 DATE AS OF CHANGE: 20090618 EFFECTIVENESS DATE: 20090618 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Tocagen Inc CENTRAL INDEX KEY: 0001419041 IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-111231 FILM NUMBER: 09898492 BUSINESS ADDRESS: STREET 1: 3030 BUNKER HILL STREET, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92109 BUSINESS PHONE: (858) 412-8400 MAIL ADDRESS: STREET 1: 3030 BUNKER HILL STREET, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92109 D 1 primary_doc.xml X0401 D LIVE 0001419041 Tocagen Inc 3030 BUNKER HILL STREET, SUITE 230 SAN DIEGO CA 92109 (858) 412-8400 None DELAWARE Corporation true 2007 Harry Gruber 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Director Thomas Darcy 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Director Douglas Jolly 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Dennis Berman 3030 Bunker Hill Street, Suite 230 San Diego CA 92109 Executive Officer Director Pharmaceuticals Decline to Disclose 06 false 2009-06-12 false true true Series C Preferred Stock false 0 5000000 1000000 4000000 Issuer may issue up to 3,125,000 shares of Series C Preferred Stock at $1.60 per share. false 1 0 0 0 false Tocagen Inc Thomas E. Darcy Thomas E. Darcy Chief Financial Officer 2009-06-18 -----END PRIVACY-ENHANCED MESSAGE-----